GlassScriptPhysician profile
Harold C Phillips
NPI 1306046297
$4,946.17
in general payments reported to CMS, 2019-2025
20 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $299 · 2021: $572 · 2022: $237 · 2023: $442 · 2024: $968 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,075.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $622.51 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $510.48 | 2023-2025 | Xiidra, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $488.24 | 2019-2025 | Cequa |
| Alcon Vision LLC | $462.37 | 2020-2025 | Tryptyr, Precision7, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $461.89 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $438.62 | 2019-2025 | Acuvue |
| Allergan, INC. | $325.24 | 2020-2021 | |
| Lkc Technologies, INC. | $261.80 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $211.49 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $145.24 | 2021 | |
| Dompe US, INC. | $139.39 | 2025 | Oxervate |
| Lumenis Be INC | $133.13 | 2024 | Optilight |
| Shire North American Group INC | $130.74 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $124.14 | 2021 | |
| Apellis Pharmaceuticals, INC. | $121.83 | 2024 | Syfovre |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $121.82 | 2023 | Acthar |
| Optos, INC. | $88.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.39 | 2019-2023 | |
| Integra Lifesciences Corporation | $67.54 | 2019 | |
| Harrow Eye, LLC | $19.07 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.